Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments
Publishing timestamp: 2023-05-01 11:28:30
Summary
Attorneys general from 23 states and two U.S. territories are calling on Medicare to provide unrestricted coverage of antibody treatments for Alzheimer's disease, adding to mounting pressure on the federal Centers for Medicare and Medicaid Services to end its controversial policy that severely restricts access to new drugs such as Eisai and Biogen's Leqembi. Medicare's decision to restrict coverage means only wealthy seniors can afford to pay $26,500 per year out of pocket. The push by members of Congress and state attorneys general comes after Medicare rejected a request by the Alzheimer's Association to cover Leqembi without any conditions.
Sentiment: POSITIVE
Keywords: politics, biogen inc, breaking news: business, business news, biotech and pharmaceuticals, u.s. economy, eisai co ltd, medicare health plans, alzheimer's disease, seniors, biotechnology, business, pharmaceutical industry regulation, health care industry, centers for medicare & medicaid services,
Source: https://www.cnbc.com/2023/05/01/states-medicare-alzheimers-treatments.html